Genetic Analysis
Genetic analysis was performed to screen for mutations in the FBN1 and TGFBR genes. Genomic DNA was isolated from the peripheral blood leukocytes of patients by an NA-3000 Nucleic Acid Isolation System (Kurabo Industries Ltd, Osaka, Japan) and amplified by polymerase chain reaction (PCR). Primers and conditions for PCR were as described previously. 1, 2, 7 Genetic variants were screened with a denaturing high-performance liquid chromatography method in which the PCR products were analyzed with a WAVE DNA Fragment Analysis System (Transgenomic Inc, Omaha, NB, USA) according to the manufacturer's protocol. All detected variations were further confirmed by direct sequencing with an ABI 3700 Autosequencing System (Applied Biosystems, Foster City, CA, USA).
Results

Genetic Analysis
The median age of the patients at the time of blood sampling for genetic analysis was 33 years (range: 9-58). Among the 18 patients with suspected MFS, 7 fulfilled the diagnostic criteria of MFS, including 2 patients with AAD and 3 with AAE. Each of these 7 patients had mutations in FBN1. Eleven of the 18 patients were not diagnosed with MFS according to the criteria, and these patients were instead classified as having a Marfan-like connective tissue disorder. Among the latter, 1 patient had mutations in type I TGFBR gene (TGFBR1), 2 had mutations in type II TGFBR gene (TGFBR2), 1 had mutations in COL3A1 and 7 did not have any mutations in the FBN1 and TGFBR genes. These 7 patients showed only reported polymorphisms in FBN1, FBN2, TGFBR1, and TGFBR2. Details of the 3 patients with TGFBR gene mutations are described below.
Clinical Course of the Patients With TGFBR Gene
Mutations Patient 1 Patient 1 was a 44-year-old woman (height, 157 cm; weight, 43 kg). She suffered the first episode of AAD (DeBakey IIIb) at the age of 29 years. Her identical twin sister also developed AAD at the same age. Surgical replacement of the proximal descending aorta for expansion of a false lumen was performed when the patient was 31 years of age. At 33 years of age, she suffered a recurrence of the AAD (IIIb), which was associated with expansion of the false lumen in the distal descending aorta to the abdominal aorta. At the age of 35 years, she suffered a third episode of AAD (II), for which emergency surgery, including total arch replacement, aortic root remodeling, and reconstruction of the right coronary artery, was performed. At 43 years of age she underwent surgical replacement of the thoracoabdominal aorta to correct expansion of the distal descending to abdominal aortic aneurysm and she also underwent the Bentall procedure for AAE with aortic regurgitation at 44 years of age. She did not show any of the following phenotypic manifestations of MFS: wrist sign, thumb sign, pectus carinatum, pectus excavatum, ectopia lentis, pneumothorax, mitral valve prolapse, striae distensae, or dural ectasia. The arm span to height ratio was <1.05. The clinical manifestations did not fulfill the diagnostic criteria for MFS, and Marfan-like connective tissue disorder was thus diagnosed. Although the patient had hypertelorism, bifid uvula, and aneurysm of aortic root, she had neither aneurysms of other vessels nor a tortuous aorta, which are typical clinical features of LDS. 2 Mutations were not detected within the FBN1. However, we did detect a mutation in exon 7 of TGFBR2, leading to an Arg-to-Cys substitution at residue 537.
Patient 2 Patient 2 was a 35-year-old man (height, 179 cm; weight, 69 kg). His mother had died from AAD and his first episode of AAD (DeBakey IIIb) occurred at 34 years of age. Replacement of the descending aorta was performed when he was 35 years of age. Although he had moderate-grade pectus excavatum, he did not show any of the following phenotypic manifestations of MFS: wrist sign, thumb sign, pectus carinatum, ectopia lentis, pneumothorax, mitral valve prolapse, striae distensae, or dural ectasia. The arm span to height ratio was <1.05. The clinical manifestations did not fulfill the diagnostic criteria for MFS, and therefore he was classified as having a Marfan-like connective tissue disorder. Although the patient had aortic root aneurysm and a tortuous aorta, he did not have hypertelorism, cleft palate, abnormal uvula, or aneurysms of other vessels, which are typical clinical features of LDS. In addition, he had exotropia. Genetic analysis detected a nonsense mutation in exon 6 of TGFBR2 that caused a stop codon instead of an Arg at amino acid position 495. We did not detect mutations in FBN1 responsible for MFS. 
Comparison of the Present Clinical Features With Those in Previous Reports
The clinical features of these 3 patients are summarized and compared with those described by Loeys et al 2, 3 and Singh et al 8 (Table 1) . Loeys et al proposed 36 clinical features of LDS, of which the median number of features examined in each patient was 31, with a median number of positive features of 13, and a median positive ratio of 46%. In the present study, the number of these 36 features examined was 36 in patient 1, 35 in patient 2, and 35 in patient 3. The number of positive features in these 3 patients was 5 in patient 1, 5 in patient 2, and 3 in patient 3, with a positive ratio therefore of 14% (5/36), 14% (5/35), and 9% (3/35), respectively, which is much less than the ratio reported by Loeys et al.
Clinical Features of Patients Without FBN1 or TGFBR Gene Mutations
The clinical features of the 8 patients without FBN1 or TGFBR gene mutations are shown in Table 2 . Among them, 1 patient had mutations of COL3A1 and was diagnosed as having Ehlers-Danlos syndrome. The remaining 7 patients showed reported polymorphisms only in FBN1, FBN2, TGFBR1, and TGFBR2. They were associated with several phenotypes of MFS such as pes planus, thumb sign, scoliosis, pectus excavatum, mitral valve prolapse, aortic dissection, and annuloaortic ectasia, but did not fulfill the criteria for MFS (Table 2 ).
Discussion
The diagnostic criteria for MFS were first established in 1986 9 and were based solely upon phenotypic abnormalities of the skeletal, ocular, and cardiovascular systems. The observation that mutations in FBN1 were linked to this syndrome required that these classic criteria be revised to include genetic factors. 6 However, mutations in FBN1 have been detected in only 66-91% of MFS patients. 10, 11 Some patients who present with Marfan-like skeletal and cardiovascular phenotypes, but who lack or exhibit only mild ocular involvement and who do not exhibit mutations in the FBN1 locus have been classified as MFS2. 12 Chromosome 3p25-p24.2 has been identified as a second locus for MFS 13 in lineages in which MFS2 was shown. This locus is also known as TAAD2 and is thought to be responsible for familial TAA and AAD. 14 There is clear evidence in the literature for the existence of at least 4 syndromes associated with mutations in TGFBR1 or TGFBR2; that is, LDS, 2 MFS2, 1 Shprintzen-Goldberg syndrome, 4 and Furlong syndrome. 5 LDS has been subdivided into types 1 and 2. 3 LDS type 1 is associated with craniofacial involvement consisting of cleft palate, craniosynostosis, or hypertelorism, whereas type 2 is associated with Ehlers-Danlos syndrome. Shprintzen-Goldberg syndrome is characterized by craniosynostosis and mental retardation, and Furlong syndrome is characterized by only craniosynostosis.
We report 3 cases of young-onset AAD associated with mutations in TGFBR1 and TGFBR2. Diagnoses of MFS and MFS2 were excluded because the patients did not fulfill the diagnostic criteria for MFS. In addition, because the patients exhibited neither craniosynostosis nor mental retardation, diagnoses of Shprintzen-Goldberg or Furlong syndromes were excluded. We also did not observe characteristics associated with Ehlers-Danlos syndrome, such as skin hyperextensibility, fragile and soft skin, delayed wound healing with formation of atrophic scars, and generalized joint hypermobility. Thus, LDS type 2 was also ruled out. Consequently, the most probable diagnosis of these 3 patients was LDS type 1. However, these 3 patients presented only a fraction of the features associated with LDS type 1; 2 only 9-14% of the 36 reported clinical features of LDS, which is far less than that reported by Loeys et al (median 46% of the 36 features). It should be also pointed out that patient 3 had repetitive pneumothorax, which is not listed in the features of LDS. These observations support the notion that TGFBR gene mutations may give rise to greater phenotypic heterogeneity than previously reported.
Finally, as described above, several syndromes have been linked to TGFBR gene mutations. Although the phenotypic manifestations of these syndromes overlap, the extent of this remains to be determined more precisely, mainly because the precise clinical features have not been evaluated and/or reported in most patients with TGFBR gene mutations. In fact, to our knowledge, the study performed by Loeys et al 3 is the only one in which as many as 36 clinical features associated with TGFBR gene mutations have been evaluated, although there are some published reports of mutations of TGFBR genes. [15] [16] [17] [18] [19] Given the current incomplete understanding of the clinical features associated with TGFBR gene mutations, more detailed clinical studies should be performed in patients who present with these mutations.
Conclusions
We described 3 cases of Marfan-like connective tissue disorder associated with TGFBR gene mutations. The clini-cal features differed from those of previously reported cases of Marfan-like connective tissue disorder associated with TGFBR gene mutations. Although the number of patients was limited, our findings support the notion that these mutations may give rise to greater phenotypic heterogeneity than previously reported.
